Do you want to read an article? Please log in or register.
Frequency of Tiotropium Bromide Use and Clinical Features of Patients with Severe Asthma in a Real-Life Setting: Data from the Severe Asthma Network in Italy (SANI) Registry
Asthma
RECOMMENDED
Related content
RECOMMENDED
Asthma
Sex Differences in Severe Asthma: Results From Severe Asthma Network in Italy-SANI
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Allergy Asthma Immunol Res
Senna G, Latorre M, Bugiani M, Caminati M, Heffler E, Morrone D, Paoletti G, Parronchi P, Puggioni F, Blasi F, Canonica GW, Paggiaro P, SANI Network.
doi: 10.4168/aair.2021.13.2.219
RECOMMENDED
Asthma
Characterisation of patients with severe asthma in the UK Severe Asthma Registry in the biologic era
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Thorax
Jackson DJ, Busby J, Pfeffer PE, Menzies-Gow A, Brown T, Gore R, Doherty M, Mansur AH, Message S, Niven R, Patel M, Heaney LG, UK Severe Asthma Registry.
doi: 10.1136/thoraxjnl-2020-215168
RECOMMENDED
Asthma
Characterization of severe asthma worldwide: data from the International Severe Asthma Registry (ISAR)
★ 3
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Chest.
Eileen W, Wechsler ME, Tran TN, Heaney LG, Jones RC, Menzies-Gow AN, Busby J, Jackson DJ, Pfeffer PE, Rhee CK, Cho YS, Canonica GW, Heffler E, Gibson PG, Hew M, Peters M, Harvey ES, Alacqua M, Zangrilli J, Bulathsinhala L, Carter VA, Chaudhry I, Eleangovan N, Hosseini N, Murray RB, Price DB
doi: 10.1016/j.chest.2019.10.053.
RECOMMENDED
Asthma
Clinical Determinants of Successful Omalizumab Therapy in Severe Allergic Asthma Patients: 4-Year-Long, Real-Life Observation
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
J Asthma Allergy
Kucharczyk A, Więsik-Szewczyk E, Poznańska A, Jahnz-Różyk K
doi: 10.2147/JAA.S282203
RECOMMENDED
Asthma
Real-World Effectiveness of Mepolizumab in Patients with Severe Asthma: An Examination of Exacerbations and Costs
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 3
Recommended by
Dr Marcus Hesse, Faculty Member
J Asthma Allergy.
Llanos JP, Ortega H, Bogart M, Packnett ER, Manjelievskaia J, Bell CF, Hahn B
doi: 10.2147/JAA.S236609.
RECOMMENDED
Asthma
Organization, Clinical and Management Indicators on the First Year of Activity of an Outpatient Clinic Dedicated to the Diagnosis and Treatment of Severe Asthma in Italy
★ 1
Recommended by
Dr Martin Frey, Faculty Member
J Asthma Allergy
Tognella S, Micheletto C, Roggeri A, Polese G, Artioli D, Senna G, Caminati M, Roggeri DP
doi: 10.2147/JAA.S309740
RECOMMENDED
Asthma
Treatment Eligibility of Real-life Mepolizumab-treated Severe Asthma Patients
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
J Allergy Clin Immunol Pract.
Richards LB, van Bragt JJMH, Aarab R, Longo C, Neerincx AH, Sont JK, Weersink EJM, Braunstahl GJ, Brinke AT, Bel EHD, Maitland-van der Zee AH
doi: 10.1016/j.jaip.2020.04.029.
Comorbidity in severe asthma requiring systemic corticosteroid therapy: cross-sectional data from the Optimum Patient Care Research Database and the British Thoracic Difficult Asthma Registry.
Thorax.
Sweeney J, Patterson CC, Menzies-Gown A, Niven RM, Mansur AH, Bucknall C, Chaudhuri R, Price D, Brightling CE, Heaney LG on behalf of the British Thoracic Society Difficult Asthma Network
doi: 10.1136/
RECOMMENDED
Asthma
Characterizing Real-World Use Of Tiotropium In Asthma In The USA
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
J Asthma Allergy.
Averell CM, Laliberté F, Duh MS, Wu JW, Germain G, Faison S
doi: 10.2147/JAA.S216932.